Physician profile
Pamela Weber
NPI 1225129273
$342.44
in general payments reported to CMS, 2019-2025
8 companies · $25.00 in 2025
The $25.00 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.01 · 2020: $51.49 · 2021: $125 · 2024: $94.94 · 2025: $25.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $69.94 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $69.94 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $125.00 | 2021 | |
| Fujifilm Corporation | $69.94 | 2024 | |
| Bard Peripheral Vascular, INC. | $51.49 | 2020 | |
| Bayer Healthcare LLC | $50.00 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $20.47 | 2019 | |
| Sanofi Pasteur INC. | $14.65 | 2019 | |
| Genentech USA, INC. | $10.89 | 2019 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pamela Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.